BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6198067)

  • 1. Characterization of antigenic components from circulating immune complexes in patients with gestational trophoblastic neoplasia.
    Lahey SJ; Steele G; Rodrick ML; Berkowitz R; Goldstein DP; Ross DS; Ravikumar TS; Wilson RE; Byrn R; Thomas P
    Cancer; 1984 Mar; 53(6):1316-21. PubMed ID: 6198067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
    Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
    J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complex levels in patients with gestational trophoblastic neoplasia.
    Rayner AA; Berkowitz R; Steele G; Schur PH; Rodrick ML; Goldstein DP; Harte PJ; Wilson RE; Zamcheck N; Munroe AE
    J Natl Cancer Inst; 1982 Jul; 69(1):23-6. PubMed ID: 6285061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunobiology of complete molar pregnancy and gestational trophoblastic tumor.
    Berkowitz RS; Umpierre SA; Taylor-Emery S; Goldstein DP; Anderson DJ
    Cancer Metastasis Rev; 1986; 5(2):109-23. PubMed ID: 3030577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.
    Begent RH; Chester KA; Walker LC; Tucker DF
    Br J Cancer; 1982 Feb; 45(2):217-22. PubMed ID: 6174138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunobiology of molar pregnancy and gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Hoch EJ; Anderson DJ
    J Reprod Med; 1984 Nov; 29(11):796-801. PubMed ID: 6097683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complex levels in patients with molar pregnancy.
    Berkowitz RS; Lahey SJ; Rodrick ML; Rayner AA; Goldstein DP; Steele G
    Obstet Gynecol; 1983 Feb; 61(2):165-8. PubMed ID: 6823357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens in husband-wife pairs with trophoblastic tumor.
    Yamashita K; Ishikawa M; Shimizu T; Kuroda M
    Gynecol Oncol; 1981 Aug; 12(1):68-74. PubMed ID: 6168517
    [No Abstract]   [Full Text] [Related]  

  • 12. The immune system in disease: gestational trophoblastic tumours.
    Newlands ES; Fisher RA; Searle F
    Baillieres Clin Obstet Gynaecol; 1992 Sep; 6(3):519-39. PubMed ID: 1332835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibitory substance to the husband's HLA allotype in sera from patients with gestational trophoblastic disease detected by lymphocytotoxicity testing.
    Kato S; Tsuji K; Furuhashi Y; Goto S; Saito M; Tomoda Y
    Am J Reprod Immunol; 1989 Aug; 20(4):126-34. PubMed ID: 2560376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA and trophoblastic tumours.
    Lawler SD
    Br Med Bull; 1978 Sep; 34(3):305-8. PubMed ID: 214197
    [No Abstract]   [Full Text] [Related]  

  • 18. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of early pregnancy factor-like activity in women with gestational trophoblastic tumors.
    Mehta AR; Shahani SK
    Am J Reprod Immunol Microbiol; 1987 Jul; 14(3):67-9. PubMed ID: 2823620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.